PharmGKB summary: methylene blue pathway

Pharmacogenet Genomics. 2013 Sep;23(9):498-508. doi: 10.1097/FPC.0b013e32836498f4.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Contraindications
  • Erythrocytes / metabolism*
  • Glucosephosphate Dehydrogenase Deficiency / complications
  • Glucosephosphate Dehydrogenase Deficiency / genetics
  • Glucosephosphate Dehydrogenase Deficiency / metabolism*
  • Hemolysis
  • Humans
  • Metabolic Networks and Pathways
  • Methemoglobinemia / complications
  • Methemoglobinemia / drug therapy*
  • Methemoglobinemia / metabolism
  • Methylene Blue / adverse effects
  • Methylene Blue / metabolism
  • Methylene Blue / therapeutic use*
  • NADP / metabolism
  • Oxidative Stress
  • Pentose Phosphate Pathway / genetics
  • Reactive Oxygen Species / metabolism

Substances

  • Reactive Oxygen Species
  • NADP
  • Methylene Blue